Evidence map›Paper›PMID 41627399›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Exploratory evaluation of early

Sarah Beishan Tai, Wei Ming Chua, Cherie Wei Qi Ng, Maria Noviani, Wei Ping Tham, Seyed Ehsan Saffari, Winnie Wing Chuen Lam, David Chee Eng Ng, Adrian Shoen Choon Seng Low, Wanying Xie and 1 more

Abstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [European journal of nuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sarah Beishan TaiDepartment of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, 16 College Road, Block 2 Basement 1, Singapore, 169854, Singapore.
Wei Ming ChuaDepartment of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, 16 College Road, Block 2 Basement 1, Singapore, 169854, Singapore.
Cherie Wei Qi NgDepartment of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, 16 College Road, Block 2 Basement 1, Singapore, 169854, Singapore.
Maria NovianiDuke-NUS Medical School, National University of Singapore, Singapore, Singapore.
Wei Ping ThamDuke-NUS Medical School, National University of Singapore, Singapore, Singapore.
Seyed Ehsan SaffariDuke-NUS Medical School, National University of Singapore, Singapore, Singapore.
Winnie Wing Chuen LamDepartment of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, 16 College Road, Block 2 Basement 1, Singapore, 169854, Singapore.
David Chee Eng NgDepartment of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, 16 College Road, Block 2 Basement 1, Singapore, 169854, Singapore.
Adrian Shoen Choon Seng LowDuke-NUS Medical School, National University of Singapore, Singapore, Singapore.
Wanying XieDepartment of Nuclear Medicine and Molecular Imaging, Singapore General Hospital, 16 College Road, Block 2 Basement 1, Singapore, 169854, Singapore. Xie.wanying@singhealth.com.sg.
Andrea Hsiu Ling LowDuke-NUS Medical School, National University of Singapore, Singapore, Singapore. Andrea.low.h.l@singhealth.com.sg.ORCID 0000-0002-5244-686X

Funding

Agency for Science, Technology and Research H24J4a0019Goh Cheng Liang Rheumatology ARISE Program Fund - Research Training Program Sponsorship Goh Cheng Liang Rheumatology ARISE Program Fund - Research Training Program SponsorshipNational Medical Research Council MOH-CSAINV19may-0005National Medical Research Council MOH-CSSDFD23janB-0001National Medical Research Council MOH-RTF23jan-0002National Medical Research Council RTF23jul-0011Rheumatology Research Foundation Rheumatology Research FoundationSingapore General Hospital SRG-OPN-02-2021
6 · The paper itself

Abstract

purposeSystemic sclerosis-associated interstitial lung disease (SSc-ILD) is a severe complication of SSc, characterised by progressive fibrosis and inflammation. Current diagnostic tools do not accurately differentiate progressors from non-progressors, limiting timely intervention.

methodsEarly (10 min) and late (60 min)

resultsEarly total lesion FAPI uptake (median TL-FAPI

conclusionThis exploratory study showed that

Indexed as

Lung Diseases, InterstitialPositron Emission Tomography Computed TomographyScleroderma, SystemicAgedEndopeptidasesFemaleFibroblast Activation Protein AlphaGallium RadioisotopesHumansMaleMiddle AgedQuinolinesTime Factors68Ga-FAPIEndopeptidasesFibroblast Activation Protein AlphaGallium RadioisotopesQuinolinesBiomarkerFibrosisMolecular imagingQuantitativeSSc-ILD

Identifiers

PMID41627399
PMCPMC13121334

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.